Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
interferon alfa
- Development stage
- Phase 4
- Lead developer
- Biogen
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Administration
- Subcutaneous, Intramuscular
01
Overview
Interferon alfa is a pharmaceutical drug composed of natural or recombinant forms of human interferon alpha (IFN-α), a type I interferon protein produced by leukocytes. It acts as an immunomodulator and antiviral agent by stimulating the innate immune response and enhancing the activity of immune cells against viruses and tumor cells. Interferon alfa is used to treat various conditions including chronic hepatitis B and C infections, hairy cell leukemia, malignant melanoma, non-Hodgkin's lymphoma, Kaposi's sarcoma (AIDS-related), follicular lymphoma, Behçet's disease, multiple myeloma, carcinoid tumor, mastocytosis and genital warts. The drug can be derived from human blood or produced using recombinant DNA technology in bacteria such as E. coli[2][3][4][5][7]. It is typically administered via subcutaneous or intramuscular injection.
- Brand names
- MultiferonIntron ARoferon-AAlferon NHeberon Alfa R
- Other names
- IFN-αinterferon alpha
02
Targets
IFNAR (Immune system modulation via type I interferon receptor)
Beyond the preview
Go deeper on interferon alfa.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on interferon alfa.